These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35481619)

  • 1. Ketoprofen-induced severe toxic epidermal necrolysis associated with vanishing bile duct syndrome leading to liver transplantation.
    Massari M; Peccerillo F; Bonzano L; Pavone P; Motolese A; Froio E; Motolese A
    J Dtsch Dermatol Ges; 2022 May; 20(5):687-689. PubMed ID: 35481619
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant.
    Kim HY; Yang HK; Kim SH; Park JH
    Yonsei Med J; 2014 May; 55(3):834-7. PubMed ID: 24719156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological analysis of pathogenic infiltrates in the epidermis and liver of a patient with toxic epidermal necrolysis accompanied by vanishing bile duct syndrome.
    Toyoda T; Hashimoto K; Ogawa Y; Tohyama M; Muto Y; Murashima T; Akao K; Honma K; Tanaka A
    J Dermatol; 2022 Dec; 49(12):1343-1347. PubMed ID: 36176039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.
    White JC; Appleman S
    Pediatrics; 2014 Oct; 134(4):e1194-8. PubMed ID: 25246624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child.
    Li L; Zheng S; Chen Y
    J Int Med Res; 2019 Sep; 47(9):4537-4543. PubMed ID: 31448655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis.
    Lin WC; Hsieh TS; Chu CY
    Front Med (Lausanne); 2022; 9():975754. PubMed ID: 36353223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of toxic epidermal necrolysis and vanishing bile duct syndrome, requiring liver transplantation.
    Momen S; Dangiosse C; Wedgeworth E; Walsh S; Creamer D
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e450-e452. PubMed ID: 28426901
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic epidermal necrolysis related to ketoprofen.
    Tijhuis GJ; Teepe RG; Smith SJ
    Dermatology; 1995; 190(2):176. PubMed ID: 7727846
    [No Abstract]   [Full Text] [Related]  

  • 9. Education and imaging. Hepatology: Rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen, requiring liver transplantation.
    Harimoto N; Wang H; Ikegami T; Takeishi K; Itoh S; Yamashita YI; Yoshizumi T; Aishima S; Shirabe K; Oda Y; Maehara Y
    J Gastroenterol Hepatol; 2015 Apr; 30(4):656. PubMed ID: 25776963
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
    Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute vanishing bile duct syndrome after the use of ibuprofen.
    Basturk A; Artan R; Yılmaz A; Gelen MT; Duman O
    Arab J Gastroenterol; 2016 Sep; 17(3):137-139. PubMed ID: 27658326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
    Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
    Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kaniwa N; Ueta M; Nakamura R; Okamoto-Uchida Y; Sugiyama E; Maekawa K; Takahashi Y; Furuya H; Yagami A; Matsukura S; Ikezawa Z; Matsunaga K; Sotozono C; Aihara M; Kinoshita S; Saito Y
    Allergol Int; 2015 Oct; 64(4):379-81. PubMed ID: 26433536
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxic epidermal necrolysis-like lupus erythematosus: a condition to exclude in all patients with possible Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Truong K; Goldinger S; Kim J; Smith A; Fernandez-Peñas P
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e218-e221. PubMed ID: 34661931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.